Needle Biopsy Market Overview
The Needle Biopsy Market is expanding steadily as technological advancements, increasing cancer prevalence, and growing preference for minimally invasive diagnostic procedures strengthen demand for advanced biopsy solutions. Integration of imaging technologies such as ultrasound and CT guidance is also improving biopsy precision and supporting wider clinical adoption.
According to the Market Research Future report updated August 24, 2026, the global Needle Biopsy Market was valued at USD 2.35 billion in 2024 and is projected to grow from USD 2.465 billion in 2025 to USD 3.982 billion by 2035, registering a 4.91% CAGR from 2025 to 2035. North America remains the largest regional market, supported by advanced healthcare infrastructure and high diagnostic imaging utilization, while Asia-Pacific is the fastest-growing region. Fine Needle Aspiration Biopsy remains the dominant type, Oncology leads by application, Ultrasound Guided procedures dominate the guidance-technique segment, and Hospitals represent the largest end-use segment.
Unlock Exclusive Insights – Request Your Free Sample Report Now!
https://www.marketresearchfuture.com/sample_request/3830
Key players driving innovation and competitiveness in the Needle Biopsy market include:
Becton Dickinson and Company, Boston Scientific Corporation, Medtronic plc, Hologic, Inc., Siemens Healthineers AG, Fujifilm Holdings Corporation, Cook Medical Incorporated, Cardinal Health, Inc., and Terumo Corporation.
The market is being driven by the rising incidence of cancer, increasing awareness of early diagnosis, growing utilization of diagnostic imaging, and a strong preference for minimally invasive procedures. Needle biopsies offer shorter recovery times and lower risks compared with traditional surgical biopsy approaches. Advances in specialized needles, ultrasound-guided systems, robotic-assisted technologies, and other imaging-enabled solutions are further improving diagnostic accuracy and patient experience.
Segmentation
The Needle Biopsy Market is segmented by Type, Application, Guidance Technique, and End Use. By type, the market includes Fine Needle Aspiration Biopsy, Core Needle Biopsy, and Vacuum-Assisted Biopsy. Applications include Oncology, Cardiology, Gastroenterology, and Pulmonology. By guidance technique, the market covers Ultrasound Guided, CT Guided, and Mammography Guided procedures, while end users comprise Hospitals, Diagnostic Laboratories, and Research Institutions.
Opportunities
Significant opportunities are emerging from advanced imaging-guided biopsy systems, improved tissue-sampling technologies, and the growing adoption of personalized medicine. The development of more precise biopsy devices can improve diagnostic outcomes, while telemedicine platforms may support remote consultations and follow-up care. The report also identifies biodegradable biopsy needles as a potential emerging opportunity for enhanced patient safety.
Recent Developments and Market Trends:
- Integration of ultrasound, CT, and other imaging technologies is improving biopsy precision and lesion targeting.
- Growing preference for minimally invasive procedures is supporting adoption across healthcare settings.
- Personalized medicine is increasing demand for accurate tissue sampling to guide targeted treatment decisions.
- Fine Needle Aspiration Biopsy remains the largest type segment, while Core Needle Biopsy is experiencing rapid growth.
- Oncology continues to dominate applications, while Pulmonology is the fastest-growing application segment.
- Ultrasound Guided biopsy maintains the largest share among guidance techniques, while CT-guided procedures are gaining traction for complex anatomical locations.
- Diagnostic laboratories are expanding rapidly as demand for precise and timely biopsy analysis increases.
Reasons to Buy the Report:
- Understand the global Needle Biopsy Market size and growth outlook through 2035.
- Analyze the market across biopsy type, application, guidance technique, and end use.
- Evaluate North America’s market leadership and Asia-Pacific’s growth potential.
- Assess major companies and competitive strategies in the biopsy-device industry.
- Identify opportunities arising from advanced imaging and minimally invasive technologies.
- Examine market drivers, trends, opportunities, and future growth prospects.
Future Outlook
The global Needle Biopsy Market is projected to grow from USD 2.465 billion in 2025 to USD 3.982 billion by 2035, reflecting a 4.91% CAGR during the forecast period. North America is expected to maintain its leadership, supported by advanced healthcare infrastructure and high utilization of diagnostic imaging. Asia-Pacific is positioned as the fastest-growing regional market as healthcare investment increases and cancer prevalence drives demand for diagnostic procedures.
By type, Fine Needle Aspiration Biopsy remains the dominant segment and is projected to reach approximately USD 1.54 billion by 2035, while Core Needle Biopsy is expected to grow from USD 0.78 billion in 2024 to USD 1.25 billion by 2035. By application, Oncology leads and is projected to increase from USD 0.94 billion in 2024 to USD 1.56 billion by 2035. Ultrasound Guided biopsy is expected to remain the leading guidance technique, reaching approximately USD 1.55 billion by 2035, while Hospitals remain the largest end-use segment, projected to grow from USD 0.94 billion in 2024 to USD 1.56 billion by 2035.
➤➤Explore Our Latest Related Reports:
